Head-to-Head

Johnson & Johnson vs. Lyell Immunopharma, Inc. Common Stock

JNJ

Johnson & Johnson

$276.32 +3.81%

VS LYEL

Lyell Immunopharma, Inc. Common Stock

$15.43 +43.27%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

JNJLYEL
Market Cap $640.75 billion $263.92 million

JNJ leads on 1 of 1 size & scale factors.

Dividend

JNJLYEL
Dividend Yield 1.94% —

JNJ and LYEL split the dividend factors evenly.

Risk & Sentiment

JNJLYEL
Short Interest 0.67% 5.38%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: JNJ overview, JNJ financials, LYEL overview, LYEL financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.